GLAXOSMITHKLINE PHARMACEUTICALS
Back to Cashflow Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-737 Cr | ₹-769 Cr | ₹-561 Cr | ₹-1,543 Cr | ₹-524 Cr |
What is the latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-737 Cr |
| Mar2025 | ₹-769 Cr |
| Mar2024 | ₹-561 Cr |
| Mar2023 | ₹-1,543 Cr |
| Mar2022 | ₹-524 Cr |
How is Cash Flow from Financing Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-737 Cr | Negative | |
| Mar2025 | ₹-769 Cr | Negative | |
| Mar2024 | ₹-561 Cr | Negative | |
| Mar2023 | ₹-1,543 Cr | Negative | |
| Mar2022 | ₹-524 Cr | - | |
Compare Cash Flow from Financing Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹45,986.2 Cr | 1.7% | 10.2% | 6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 1.7% |
10.2% |
6.5% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses